1. Optimizing leading edge F-actin labeling using multiple actin probes, fixation methods and imaging modalities
- Author
-
John S. Condeelis, Robert J. Eddy, Ved P. Sharma, Vera DesMarais, and Orrin J. Stone
- Subjects
Leading edge ,Phalloidine ,medicine.drug_class ,Phalloidin ,Motility ,macromolecular substances ,Monoclonal antibody ,01 natural sciences ,Antibodies ,General Biochemistry, Genetics and Molecular Biology ,Maleimides ,03 medical and health sciences ,chemistry.chemical_compound ,medicine ,Pseudopodia ,Actin ,Fluorescent Dyes ,030304 developmental biology ,0303 health sciences ,010401 analytical chemistry ,Actin cytoskeleton ,Fluorescence ,Actins ,0104 chemical sciences ,Actin Cytoskeleton ,chemistry ,Biophysics ,Lamellipodium ,Biotechnology - Abstract
We systematically evaluated the performance and reliability of several widely used, commercially available actin-filament probes in a highly motile breast adenocarcinoma cell line to optimize the visualization of F-actin-rich dynamic lamellipodia. We evaluated four Phalloidin-fluorophores, two anti-actin antibodies, and three live-cell actin probes in five fixation conditions across three imaging platforms as a basis for the design of optimized protocols. Of the fluorescent phalloidin-dye conjugates tested, Alexa Fluor-488 Phalloidin ranked best in overall labeling of the actin cytoskeleton and maintenance of the fluorescence signal over time. Use of actin monoclonal antibodies revealed significant limitations under a variety of fixation–permeabilization conditions. Evaluation of commonly used live-cell probes provides evidence for actin filament bias, with TagRFP-Lifeact excluded from lamellipodia, but not mEGFP-Lifeact or F-tractin-EGFP.
- Published
- 2019
- Full Text
- View/download PDF